Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://bushragnyr524979.blogunteer.com/37783840/retaglutide-a-promising-glp-1-receptor-agonist